This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Common Mechanisms of Neurodegeneration
joint with Microglia in the Brain
Organizer(s): Bradley T. Hyman, Adriano M. Aguzzi and Ricardo E. Dolmetsch
Date: June 12 - 16, 2016
Location: Keystone Resort, Keystone, CO, USA
Sponsored by BioLegend, Inc., Curemark LLC, FORUM Pharmaceuticals Inc., Merck & Co., Inc., Sangamo BioSciences, Inc. and Takeda Pharmaceutical Company Limited
Summary of Meeting:
Recent advances in understanding the genetics and underlying mechanisms of neurodegenerative diseases including prion diseases, Alzheimer’s, Parkinson’s, ALS and frontotemporal dementia have revealed overlaps of phenotypes, genetic risks and biological mechanisms across this spectrum of disorders. The “common mechanisms” include protein templating, glial and inflammatory mechanisms, new understanding of RNA-based toxicity and of toxicity associated with protein misfolding, and common downstream mechanisms affecting synaptic function. Moreover, because there appear to be common mechanisms at play, recent progress in therapeutic approaches targeting one of these disorders may have applicability across the whole range of disorders. This Keystone Symposia conference will enable the in-depth exploration of these various aspects of commonality across neurodegenerative disorders.
Scholarship Deadline: February 11 2016
Discounted Abstract Deadline: February 11 2016
Abstract Deadline: March 10 2016
Discounted Registration Deadline: April 12 2016
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
BioLegend, Inc.Curemark LLCFORUM Pharmaceuticals Inc.Merck & Co., Inc.Sangamo BioSciences, Inc.Takeda Pharmaceutical Company Limited
We gratefully acknowledge additional support for this conference from:
Bethyl Laboratories, Inc.Bio-TechneNovartis Institutes for BioMedical Research
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Eli Lilly and Company

Novartis Institutes for BioMedical Research
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
NeuroscientistNews
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1R13NS096941-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found